You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
By Doug Macron
NEW YORK (GenomeWeb News) – Sequenom has sued both Aria Diagnostics and Natera, accusing the companies of infringing a Sequenom patent with their respective noninvasive trisomy 21 and paternity tests.
A US District Court last week rejected a request for dismissal of a lawsuit Cold Spring Harbor Laboratory filed against legal firm Ropes & Gray for allegedly mishandling patent applications.
NEW YORK (GenomeWeb News) — Prenatal diagnostics company Natera has sued Sequenom, claiming that it does not infringe a patent on noninvasive prenatal diagnosis methods held by Sequenom.
New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.
According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.
The US National Institutes of Health has a new initiative to address structural racism in biomedical research.
In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.